tiprankstipranks
Trending News
More News >
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF

Compare Immutep Ltd (PRRUF) vs. Competitors

Compare
24 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immutep Ltd
$0.25
$448.18M
-9.30
27.78%
3 Buy
0 Hold
0 Sell
Strong Buy
Imugene
AU$0.34
AU$103.93M
-1.06
-74.74%
0 Buy
0 Hold
0 Sell
Moderate Buy
Alterity Therapeutics
AU$0.01
AU$87.00M
-5.26
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Dimerix Limited
AU$0.54
AU$330.22M
-22.48
3.88%
Race Oncology Ltd.
AU$2.70
AU$529.98M
-109.45
135.16%
Arovella Therapeutics Limited
AU$0.08
AU$105.70M
-13.09
-51.89%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRRUF
Immutep Ltd
0.25
0.06
28.43%
AU:IMU
Imugene
0.34
-1.03
-75.37%
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-44.44%
AU:DXB
Dimerix Limited
0.54
>-0.01
-0.93%
AU:RAC
Race Oncology Ltd.
3.01
1.71
131.54%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-53.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts